Eye Diseases "Treated" With Interoperable Medical Informatics

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Muenster

About this trial

The overarching goal of EyeMatics is to promote an interoperable, sustainable infrastructure for the integration and sharing of data from clinical research to improve personalized medicine in ophthalmology. To achieve this, EyeMatics bundles the expertise and preliminary work of the four consortia of the Medical Informatics Initiative (MII) and the ophthalmological centers of excellence in Germany. The perspective and concerns of patients will be strongly incorporated into the project work through close cooperation with patient representatives and the inclusion of patient feedback on quality of life and treatment success.

EyeMatics aims to improve the understanding of the therapeutic success of eye diseases that are usually treated with intravitreal surgical medication (IVOM). To this end, an exemplary analysis platform for "real" clinical data will be provided and a dashboard for data visualization and analysis will be developed as a web application. The dashboard is to be introduced at all participating hospital sites for research purposes.

Eligibility criteria

Qualifiers

OPS code: "5-156.9 Injection of drugs into the posterior segment of the eye"

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University Hospital Muenster

Lead sponsor

University Medicine Greifswald

Collaborator

University Medical Center Mainz

Collaborator

University Hospital, Aachen

Collaborator

Klinikum Chemnitz gGmbH

Collaborator

Technische Universität Dresden

Collaborator

University of Leipzig

Collaborator

University Hospital Tuebingen

Collaborator

Deutsche Ophthalmologische Gesellschaft e.V.

Collaborator

Pro Retina Deutschland e.V.

Collaborator